Legend Biotech Corporation (NASDAQ: LEGN) is a Healthcare company (Biotechnology) with a market capitalization of $3.0B. The Maz Rating grades it against the other companies in its sector.
Legend Biotech Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $15.99, Legend Biotech Corporation trades at 2.2x sales and 2.3x book value, with an EV/EBITDA of 26.8. Over the last twelve months it generated about $1.4B of revenue and a net loss of $2M. It runs a gross margin of 57.0%, an operating margin of 2.5% and a net margin of -0.0%. It shows return on equity of -0.0%, return on invested capital of -0.0% and a free cash flow yield of -10.9%. On the balance sheet: a debt-to-equity ratio of 0.13 and a current ratio of 3.95. Over the past 52 weeks the share price ranged from $15.97 to $37.50, with a beta of 0.40.
Legend Biotech Corporation does not currently pay a dividend.
20 Wall Street analyst ratings cover the stock: 14 Buy and 6 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.